The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Containment - Understanding Why, When, and What Regulatory Agencies Expect | For10 years - the Risk Based Manufacture of Pharmaceutical Products has defined expectations for cross contamination control to protect patients. Understand what cross contamination control: why it is needed, when it is needed, how to determine the extent of what is needed, and what the regulatory environment is regarding cross contamination control to protect patients. This protection translates into requirements to also protect operators.
Session Leader(s):
Christa
B. Myers,
Sr. Fellow - Aseptic and Sterile Products, Vertical Market Leader,
CRB
Speaker(s):
Tom
Evans,
Director; Environmental Health and Safety,
Abzena
Christoph
Knoop,
PhD.,
Principal Research Scientist,
AbbVie Deutschland GmbH & Co. KG
Matthias
Angelmaier,
Global Product Manager, Isolator Technology,
Syntegon Technology GmbH
You must be logged in and own this session in order to
post comments.
